Related News
Home » Sports » American Football
Network seeks to clarify Manning controversy
Print Edition
Al Jazeera insisted it had never alleged Denver Broncos quarterback Peyton Manning used human growth hormone, the most explosive insinuation in the network’s major investigation into doping in sports.
Al Jazeera reporter Deborah Davies attempted to clarify the report in a follow up on NBC’s “Today” show on Tuesday saying that the documentary had not stated that Manning had used the banned substance.
“We have not said that in the program,” said Davies.
Davies said the report had merely cited a former employee of the Guyer Institute in Indianapolis, Charlie Sly, who claimed to have knowledge that HGH was shipped to Manning’s wife Ashley.
“The only allegation in the program from Charlie Sly is that growth hormone was sent repeatedly from the Guyer to Ashley Manning in Florida,” she said. “We’re not making the allegation against Peyton Manning.”
Manning has threatened to sue over the report.
“Let’s make it clear what the allegation is. The allegation in the program is very simple, that when Charlie Sly worked in the Guyer doing part of his training ... the clinic was sending out not one shipment but repeated shipments of growth hormone to Ashley Manning in Florida. That’s it,” Davies said.
Most media following up on Al Jazeera’s report have seen a clear implication made in the documentary, “The Dark Side,” that Peyton Manning was the eventual recipient of the drug shipments.
In report, Sly said: “All the time, we would be sending Ashley Manning drugs. Like growth hormone, all the time, everywhere, Florida.
“And it would never be under Peyton’s name, it would always be under her name.”
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
